首页|穴位贴敷辅助治疗小儿肺炎支原体肺炎有效性及安全性的Meta分析

穴位贴敷辅助治疗小儿肺炎支原体肺炎有效性及安全性的Meta分析

扫码查看
目的:系统评价中药穴位贴敷辅助治疗小儿肺炎支原体肺炎的疗效.方法:在中国知网、维普、万方、PubMed数据库中检索从建库至2023年3月所有相关中英文文献,纳入穴位贴敷辅助治疗小儿肺炎支原体肺炎的随机对照试验,采用Cochrane协作网偏倚风险评估工具对纳入文献进行质量评价,通过RevMan 5.4软件进行Meta分析.结果:纳入15个随机对照试验,共1 689例患者,其中治疗组846例、对照组843例.Meta分析结果显示,中药穴位贴敷辅助治疗小儿肺炎支原体肺炎时可以显著提高总有效率[比值比(OR)=4.66,95%置信区间(CI)(3.01,7.23),P<0.000 1],提高治愈率[OR=3.05,95%CI(2.18,4.28),P<0.00001],更快缓解发热[均数差(MD)=-1.39,95%CI(-1.58,-1.19),P<0.00001]、咳嗽症状[MD=-1.89,95%CI(-2.20,-1.57),P<0.000 01],加快肺部啰音消失时间[MD=-1.82,95%CI(-2.19,-1.46),P<0.000 01].治疗组的胸部X线炎症范围明显缩小[MD=-2.5,95%CI(-3.18,-1.83),P<0.000 01],炎症因子超敏 C 反应蛋白(C-reactive Protein,CRP)[MD=-5.35,95%CI(-9.27,-1.43),P=0.007]和肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)[MD=-3.75,95%CI(-5.19,-2.86),P<0.000 01]均降低,还可降低不良反应[OR=0.43,95%CI(0.24,0.77),P=0.004],差异均有统计学意义(均P<0.05).结论:中药穴位贴敷辅助治疗小儿肺炎支原体肺炎疗效显著,总有效率、治愈率得到明显提高,可更快缓解相关症状(发热、咳嗽、肺部啰音),降低炎症反应和不良反应.
A Meta-analysis of the efficacy and safety of acupoint application in the adjuvant treatment of mycoplasma pneumoniae pneumonia in children
Objective:To systematically evaluate the therapeutic effect of acupoint application of Chinese medicine in the adjuvant treatment of mycoplasma pneumoniae pneumonia in children.Methods:All relevant Chinese and English studie were searched in CNKI,VIP,Wanfang and PubMed databases from the establishment of the database to March 2023.Randomized controlled trials involving acupoint application for adjuvant treatment of pediatric mycoplasma pneumoniae pneumonia were included.The Cochrane network bias risk assessment tool was used to evaluate the quality of the included litera-tures.Meta-analysis was performed using RevMan 5.4 software.Results:A total of 15 randomized controlled trials were included,with a total of 1 689 patients,846 cases in the treatment group and 843 cases in the control group.The results of Meta-analysis showed that Chinese medicine acupoint application in the adjuvant treatment of pediatric mycoplasma pneumonias pneumonia could significantly improve the effective rate[OR=4.66,95%CI(3.01,7.23),P<0.000 1],and improve the cure rate[OR=3.05,95%CI(2.18,4.28),P<0.000 01].It had faster relief of fever[MD=-1.39,95%CI(-1.58,-1.19),P<0.000 01],cough symptoms[MD=-1.89,95%CI(-2.20,-1.57),P<0.000 01],faster disappearance of lung rales[MD=-1.82,95%CI(-2.19,-1.46),P<0.000 01].In the treatment group,the range of chest X-ray inflammation lesions was significantly reduced[MD=-2.5,95%CI(-3.18,-1.83),P<0.000 01],and the inflammatory factor hypersensitive C-reactive protein(CRP)[MD=-5.35,95%CI(-9.27,-1.43).P=0.007]and tumor necrosis factor-α(TNF-α)[MD=-3.75,95%CI(-5.19,-2.86),P<0.000 01]were decreased,and adverse reactions were also decreased[OR=0.43,95%CI(0.24,0.77),P=0.004].The differences were statistically significant(P<0.05).Conclusion:Based on the current evidence,Chinese medicine acupoint application is effective in the adjuvant treatment of pediatric mycoplasma pneumo-niae pneumonia,the effective rate and cure rate have been significantly improved,and related symptoms(fever,cough,pulmonary rales)can be relieved faster,and inflammation and adverse reactions can be reduced.

Mycoplasma pneumoniae pneumonia in childrenAcupoint applicationExternal treatment of Chinese medicineMeta-analysis

樊晶晶、谢静

展开 >

湖南中医药大学第一附属医院,湖南 长沙,410007

小儿肺炎支原体肺炎 穴位贴敷 中医外治法 Meta分析

湖南省中医药管理局科研项目

A2023047

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(15)